-
Diagnostics World | Researchers from Johns Hopkins University and the Risk Management Foundation of the Harvard Medical Institutions have come up with a national estimate of serious harms from diagnostic error.
Sep 13, 2023
-
Diagnostics World | The recent discovery that the metastatic spread of breast cancer accelerates during sleep sparked a lively conversation at last month’s Next Generation Dx Summit about new paths of exploration for thwarting a deadly pan-cancer process claiming 12 lives worldwide every minute.
Sep 12, 2023
-
Diagnostics World | Researchers in the Czech Republic succeeded in using ChatGPT (Chat Generative Pre-trained Transformer) to produce a convincing scientific article in only one hour with no special human training—a feat intended to point out the current capabilities of large language models (LLMs).
Sep 7, 2023
-
Diagnostics World News | Illumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Illumina’s next Chief Executive Officer, effective September 25, 2023.
Sep 5, 2023
-
Diagnostics World | Medicare, the single largest payer for healthcare in the United States, has a hodgepodge of national and state policies capable of bankrupting innovation in molecular diagnostics. It is an inequitable, fiscally perplexing, needlessly verbose, and fraud-prone system but, if there’s a bright spot, it’s the Molecular Diagnostic Services Program (MolDX) responsible for technology assessments and claims disbursement for more than half the country.
Sep 5, 2023
-
Diagnostics World | Illumina and Pillar partner up to make Pillar’s oncology assays commercially available on a global scale; C2N Diagnostics releases the PrecivityAD2 blood test, a clinical care assay that meets the standard of care with currently available PET scans and cerebrospinal fluid tests; University of Missouri researchers developed an innovative method using nanopores; more.
Aug 31, 2023
-
Diagnostics World | ADARx Pharmaceuticals will use financing for treatment of a broad range of diseases; A-Alpha Bio plans to use Series A2 funding to accelerate antibody discovery and development for emerging biothreats, including HIV; Cytomos will scale-up market testing of its technology platform for cell analysis; more.
Aug 30, 2023
-
Diagnostics World | The U.S. Food and Drug Administration (FDA) has been making moves signaling its intention to better align the regulatory framework for companion diagnostics (CDx) to what is happening in real-world clinical practice.
Aug 24, 2023
-
Diagnostics World | Public health agencies have grappled with a succession of data problems associated with the COVID-19 pandemic, most notably how to accurately track prevalence rates when people are self-testing in the privacy of their home and don’t necessarily need or want to report the results.
Aug 23, 2023
-
Diagnostics World | Over the next three years, researchers from across five universities in Germany will be using “swarm learning” on retrospective tissue samples to gain insights on the tumor biology of hereditary colorectal cancer (CRC).
Aug 22, 2023
-
Diagnostics World | In a surprising twist, researchers at Sanford Burnham Prebys have found that both age and sex may matter a great deal when it comes to the consequences of many types of cancer.
Aug 16, 2023
-
Diagnostics World | Researchers at the University of Virginia School of Medicine have identified early biomarkers linked to preeclampsia that could help OB/GYNs better understand which of their patients are at risk of developing the potentially deadly pregnancy complication and perhaps help get at why the condition occurs in the first place.
Aug 15, 2023
-
Diagnostics World | Researchers at the Swiss Federal Institute of Technology Lausanne (EPFL) have developed a novel biosensing tool combining multiple advanced technologies that shows promise in detecting misfolded proteins indicative of neurodegenerative diseases such as Parkinson’s and Alzheimer’s.
Aug 10, 2023
-
Diagnostics World | The liver carries out a variety of complex roles ranging from secretion and storage to metabolism and detoxification, and researchers across the globe see the potential of using liver-on-a-chip and liver organoid technologies to improve our understanding of this organ and find better ways of diagnosing and treating the diseases and conditions that hinder its normal operation.
Aug 9, 2023
-
Diagnostics World | A point-of-care (POC) diagnostic test for long COVID is under development that would be a godsend to the millions of Americans still suffering the health consequences of SARS-CoV-2 months after being infected.
Aug 8, 2023
-
Diagnostics World | A team of researchers from North America and Europe have identified a panel of 83 markers in the blood of children genetically predisposed to develop type 1 diabetes that looks promising as a predictor of which individuals will progress to islet autoimmunity six months prior to its onset.
Aug 3, 2023
-
Diagnostics World | Carenostics is a healthcare AI startup founded with the mission of addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML on existing healthcare data.
Aug 2, 2023
-
Diagnostics World | Quest Diagnostics has launched its first consumer-initiated genetic test, the Allen Institute for Immunology and Eli Lilly and Company will collaborate to better understand disease molecules, and Cleveland Diagnostics opened a new facility for further prostate cancer testing. Plus, new partnerships and products from Lifebit, Allen Institute for Neural Dynamics, Critical Path Institute, and more.
Jul 27, 2023
-
Diagnostics World | AI platform used for acute immune states, acquisitions, solutions portfolio expansion, and more.
Jul 26, 2023